Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand

ConclusionsAt its current price in Thailand, sacubitril-valsartan may not represent good value for the nations ’s limited healthcare resources. The cost of sacubitril-valsartan needs to reduce by approximately 2% to yield an ICER below the threshold.

Source: American Journal of Cardiovascular Drugs - October 1, 2018 Category: Cardiology Source Type: research